ALNYLAM PHARMACEUTICALS INC
ALNY·02043Q107·US·Common Stock·Healthcare - Biotechnology-13D/G
ALNY (ALNYLAM PHARMACEUTICALS INC) is held by 285 institutional investors as of Q2 2026. Largest holders: FMR LLC ($4.5B), Capital World Investors ($3.4B), BlackRock, Inc. ($3.3B). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 150 funds bought ALNY.
285
Holders
(23 Elite)
$36.4B
Total Value
52% (290)
Consensus
150 buying - 140 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Apr 7, 2026 · Activists May 14, 2026 · Congress Jun 22, 2025
InsiderMMMcLaughlin MelissaSell $18KApr 6, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 303
1 / 16
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer